Document is current
Any future updates will be listed below
-
Authors
Maskalenko, Nicholas A. https://orcid.org/0000-0001-7690-5234
Zhigarev, Dmitry https://orcid.org/0000-0002-8227-3875
Campbell, Kerry S. https://orcid.org/0000-0003-4665-7326
- License Information
-
More Information
Article History
Accepted: 24 January 2022
First Online: 21 March 2022
Competing interests
: K.S.C. has received research support from Janssen Pharma, Genentech, Horizon Pharma, ImmunityBio and Immune Oncology Biosciences, consulting fees from Immunitas and Tavotec, and has patents with ImmunityBio. The other authors declare no competing interests.
